Koninklijke Philips N.V. (NYSE:PHG) Q4 2025 Earnings Call Transcript February 10, 2026 Koninklijke Philips N.V. beats earnings expectations. Reported EPS is $0.7, expectations were $0.504. Operator: ...
Investing.com -- Koninklijke Philips NV (AS:PHG) posted a stronger fourth quarter on Tuesday, reporting a 7% rise in ...
Orders accelerated, margins expanded, and cash flow held up despite tariffs and the long shadow of Respironics.
Shares in medical technology company Philips rose sharply on Tuesday as the company published better than expected results for last year and forecast a further improvement in profitability. The ...
Amsterdam, February 10, 2026Full year and Q4 highlights Comparable order intake growth 6% in 2025; up 7% in Q4Group sales of EUR 17.8 billion in 2025, EUR 5.1 billion in Q4; comparable sales growth ...
Investing.com -- Koninklijke Philips NV (AS:PHG) posted a stronger fourth quarter on Tuesday, reporting a 7% rise in comparable sales and a 160-basis-point improvement in adjusted EBITA margin to ...
Amsterdam, February 10, 2026Full year and Q4 highlightsComparable order intake growth 6% in 2025; up 7% in Q4Group sales of EUR 17.8 billion in ...
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that Roy Jakobs is proposed to be re-appointed as its President/Chief Executive ...
CHICAGO—ASSEMBLY is seeking nominations for its 2026 Assembly Plant of the Year award. The 23rd annual award will recognize a manufacturing facility in the United States that has applied world-class ...
The high flow oxygen therapy (HFOT) market is expected to expand at a compound annual growth rate (CAGR) of approximately 7% during the forecast period. This growth is primarily driven by the ...
Peer-reviewed Phase 2 Results Inform Ongoing Phase 3/Pivotal Trial of Celeste® in Parkinson’s Disease The Phase 2 study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results